Metabolomic approaches to phenotype characterization and applications to complex diseases.
about
Shotgun metabolomics approach for the analysis of negatively charged water-soluble cellular metabolites from mouse heart tissueObesity and psychotic disorders: uncovering common mechanisms through metabolomicsWaterborne manganese exposure alters plasma, brain, and liver metabolites accompanied by changes in stereotypic behaviorsQuantitative profiling method for oxylipin metabolome by liquid chromatography electrospray ionization tandem mass spectrometryA systems biology strategy reveals biological pathways and plasma biomarker candidates for potentially toxic statin-induced changes in muscleHighly-parallel metabolomics approaches using LC-MS for pharmaceutical and environmental analysis.Acquired obesity is associated with changes in the serum lipidomic profile independent of genetic effects--a monozygotic twin study.Normalization method for metabolomics data using optimal selection of multiple internal standards.PPAR gamma 2 prevents lipotoxicity by controlling adipose tissue expandability and peripheral lipid metabolism.Elevated pro-inflammatory and lipotoxic mucosal lipids characterise irritable bowel syndrome.Metabolic regulation in progression to autoimmune diabetesPPARα-dependent exacerbation of experimental colitis by the hypolipidemic drug fenofibrate.Bile acid signaling in lipid metabolism: metabolomic and lipidomic analysis of lipid and bile acid markers linked to anti-obesity and anti-diabetes in mice.Dose-dependent metabolic alterations in human cells exposed to gamma irradiation.Stable isotope-labeled tracers for metabolic pathway elucidation by GC-MS and FT-MS.Pharmacogenomics of long-acting β2-agonists.An investigation of fecal volatile organic metabolites in irritable bowel syndrome.Gender-dependent progression of systemic metabolic states in early childhood.Mass Spectrometry-Based Multiplexing for the Analysis of Biomarkers in Drug Development and Clinical Diagnostics- How Much is too Much?Metabolomics Study of Resina Draconis on Myocardial Ischemia Rats Using Ultraperformance Liquid Chromatography/Quadrupole Time-of-Flight Mass Spectrometry Combined with Pattern Recognition Methods and Metabolic Pathway Analysis.Dysregulation of lipid and amino acid metabolism precedes islet autoimmunity in children who later progress to type 1 diabetesMetabolomics in biomarker discovery: future uses for cancer prevention.Effect of probiotic Lactobacillus rhamnosus GG intervention on global serum lipidomic profiles in healthy adults.Biomarker discovery in animal health and disease: the application of post-genomic technologies.Pathogenesis of type 1 diabetes: lessons from natural history studies of high-risk individuals.The search for peripheral disease markers in psychiatry by genomic and proteomic approaches.Analysis of metabolomic patterns in thoroughbreds before and after exercise.Age- and islet autoimmunity-associated differences in amino acid and lipid metabolites in children at risk for type 1 diabetes.Plasma metabolic profiling of dairy cows affected with clinical ketosis using LC/MS technology.Systems medicine and the integration of bioinformatic tools for the diagnosis of Alzheimer's disease.Comparison of lipid and fatty acid composition of the liver, subcutaneous and intra-abdominal adipose tissue, and serum.Ion Mobility Spectrometry-Mass Spectrometry Coupled with Gas-Phase Hydrogen/Deuterium Exchange for Metabolomics Analyses.Apolipoprotein A-I mimetic peptide inhibits atherosclerosis by altering plasma metabolites in hypercholesterolemia.Microdosing, isotopic labeling, radiotracers and metabolomics: relevance in drug discovery, development and safety.Evaluating Potential Biomarkers of Health and Performance in Veal Calves.Systems Biology in Food and Nutrition ResearchMetabolomic strategies to identify tissue-specific effects of cardiovascular drugs
P2860
Q24605698-BD9C2583-30DA-479D-89AE-372456A659B0Q27011617-F46F1B59-8FC8-4A23-94F6-614C0B550FD8Q28396163-7A7D0399-E48F-4D4A-90D7-176AA74EB0D7Q28397076-F517DF8A-C9CC-4A41-BE0B-E25FEFBF16F9Q28469099-EFC358D1-0B30-47BF-8E10-6D08A98A11A5Q30380720-EB9A687B-F395-4CFF-BBBD-2C0C8FE1C15CQ30829796-BBC1B6EE-B751-45AF-8402-39CC19F76509Q31105641-140F3A85-D04F-4909-B0FE-EEC95A54B2E4Q33283063-EA5C81FF-2A4D-4EE7-95B8-0CEDB12D3625Q33555354-EB932413-1C9C-4C99-9964-9A16D8241E3DQ34064185-5CC5915F-9FB3-4B65-9CB0-D6762447FF19Q34131110-23630074-5BF7-4ECD-884F-25A659A895B5Q34451281-8AA30942-C049-4154-A9F8-2D701CF479E1Q34566189-1BC18B13-BA38-42BD-BDEB-F383FD704A31Q35109445-CAD4733B-9948-4D8C-8B9A-FEB6C6355649Q35734012-65A9B4E2-F238-4E52-9B9E-4C899BD6844FQ36680897-BC7FCAE0-1F39-4D81-A52D-7A17D9170285Q36790273-2C388C35-AAB8-4256-89A0-67B72346E43DQ36807326-0705F8C2-DD20-485B-A444-8DAA0E9B78FBQ36916074-260F05F5-C64E-41AB-AF14-DBD6BFCD2D6AQ37019642-C28351BE-E06F-4A5D-9856-68928B4FB0BFQ37074142-729DE1EF-5D7E-4A64-AFB1-512AABCF4DE8Q37267287-584EDC60-4055-4365-9BF6-A50A0074AD66Q37280937-A36E17D6-4B1B-48A1-BE90-F2C1B1185BE5Q38077588-FFFEE81B-2553-4CE1-B57C-3E97CB46817BQ38089247-90E4BAF7-FF9F-4C1E-9809-C80FC94754BAQ38669715-66B80416-737E-4429-8817-AEE4DDF0AC49Q38774633-FA0EB8C3-C663-4912-9D56-4CB60E6F4C96Q39116412-416D22F3-578A-4BB8-8061-97E0B8BC0422Q41661052-416DFB1D-DC80-442D-A501-CE989C68307AQ43637127-D145B197-0E90-41EE-8E4A-37BD387A51D8Q45068622-B8700702-97E4-4CAD-928C-4DE1838022C2Q47849940-A214B3A6-9DED-4D79-85DE-8651EFA5295BQ49679493-E46E165E-636E-4DD9-ABB1-28207E88C44FQ55411503-699E2EA1-CC57-4616-A3C6-3D5A778B2EEBQ57012121-6AD09502-CB3B-4B0E-933D-76CB8FEF3F99Q57012269-1F1D478F-1329-4BC7-B264-826C7A74FA69
P2860
Metabolomic approaches to phenotype characterization and applications to complex diseases.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Metabolomic approaches to phen ...... lications to complex diseases.
@ast
Metabolomic approaches to phen ...... lications to complex diseases.
@en
type
label
Metabolomic approaches to phen ...... lications to complex diseases.
@ast
Metabolomic approaches to phen ...... lications to complex diseases.
@en
prefLabel
Metabolomic approaches to phen ...... lications to complex diseases.
@ast
Metabolomic approaches to phen ...... lications to complex diseases.
@en
P2860
P356
P1476
Metabolomic approaches to phen ...... lications to complex diseases.
@en
P2093
Antonio Vidal-Puig
Virve Hänninen
P2860
P304
P356
10.1586/14737159.6.4.575
P50
P577
2006-07-01T00:00:00Z